Global Vascular Stents Market to Reach $13.3 Billion by 2030
The global market for Vascular Stents estimated at US$9.5 Billion in the year 2022, is projected to reach a revised size of US$13.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2022-2030. Balloon-Expandable Stents, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$9.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Self-Expandable Stents segment is readjusted to a revised 3% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 7.9% CAGR
The Vascular Stents market in the U.S. is estimated at US$2.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.5% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.Select Competitors (Total 26 Featured) -
- Abbott Laboratories, Inc.
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Endologix, Inc.
- Jotec GmbH
- Lombard Medical Technologies, Inc.
- Medtronic PLC
- Meril Life Sciences Pvt., Ltd.
- MicroPort Scientific Corporation
- Terumo Corporation
- Translumina GmbH
- Vascular Concepts Ltd.
- W.L. Gore & Associates, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories, Inc.
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Endologix, Inc.
- Jotec GmbH
- Lombard Medical Technologies, Inc.
- Medtronic PLC
- Meril Life Sciences Pvt., Ltd.
- MicroPort Scientific Corporation
- Terumo Corporation
- Translumina GmbH
- Vascular Concepts Ltd.
- W.L. Gore & Associates, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 186 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 9.5 Billion |
Forecasted Market Value ( USD | $ 13.3 Billion |
Compound Annual Growth Rate | 4.3% |
Regions Covered | Global |